|
RAB3D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.15320041983136E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.24370546983732E-11 |
| Normal-vs-Stage2 |
1.574340E-04 |
| Normal-vs-Stage3 |
4.55500000051678E-07 |
| Normal-vs-Stage4 |
7.09349999850062E-08 |
| Stage1-vs-Stage2 |
4.277600E-01 |
| Stage1-vs-Stage3 |
3.164400E-01 |
| Stage1-vs-Stage4 |
6.493400E-01 |
| Stage2-vs-Stage3 |
9.467800E-01 |
| Stage2-vs-Stage4 |
7.068800E-01 |
| Stage3-vs-Stage4 |
6.667600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.61919999630555E-09 |
| Normal-vs-AfricanAmerican |
1.49649999947599E-07 |
| Normal-vs-Asian |
1.13300002713146E-09 |
| Caucasian-vs-AfricanAmerican |
1.413170E-01 |
| Caucasian-vs-Asian |
1.117790E-01 |
| AfricanAmerican-vs-Asian |
7.713400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.85269960168478E-10 |
| Normal-vs-Female |
3.49190010240363E-10 |
| Male-vs-Female |
4.396600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.45460360107586E-11 |
| Normal-vs-Age(41-60Yrs) |
6.82559997411403E-09 |
| Normal-vs-Age(61-80Yrs) |
3.60859999992691E-07 |
| Normal-vs-Age(81-100Yrs) |
1.739620E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.011400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.202400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.883700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.870800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.095000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.076000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.188600E-01 |
| Classical-VS-Follicular |
1.574010E-01 |
| Classical-VS-Other |
5.637000E-01 |
| Classical-VS-Normal |
1.72449832192001E-11 |
| Tall-VS-Follicular |
4.877800E-01 |
| Tall-VS-Other |
6.397600E-01 |
| Tall-VS-Normal |
3.246200E-04 |
| Follicular-VS-Other |
3.742400E-01 |
| Follicular-VS-Normal |
1.77413999999931E-05 |
| Other-VS-Normal |
6.427800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.71530001313869E-09 |
| Normal-vs-N1 |
1.231390E-04 |
| N0-vs-N1 |
2.982200E-01 |
|
|
